MD Anderson in Katy
Houston, Texas 77094
1 studies enrolling now · 13 studies all time
What they study most
Advanced Malignant Solid Neoplasm, Atypical Endometrial Hyperplasia, Borderline Resectable Pancreatic Adenocarcinoma, Breast Adenocarcinoma, Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Estrogen Receptor Negative, Estrogen Receptor Positive, Estrogen Receptor-positive Breast Cancer, Fallopian Tube Clear Cell Adenocarcinoma
Studies at this site
- Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer — Recruiting now
- Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — Completed
- Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor — Running, not enrolling
- Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery — Running, not enrolling
- Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer — Running, not enrolling
- DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer — Running, not enrolling
- Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer — Running, not enrolling
- Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer — Stopped early
- Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer — Running, not enrolling
- Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer — Completed
- Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer — Completed
- Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients — Completed
- Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — Completed